Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Nature Medicine
|
September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors
Julia E Neumann, Annika K Wefers, Sander Lambo, et al.
Cancer Discovery
|
July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
Briana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Cancer Cell
|
January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation
Serap Erkek, Pascal D Johann, Martina A Finetti, et al.
Developmental Cell
|
June 4, 2024
Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression
Ryo Shiraishi, Gabriele Cancila, Kohei Kumegawa, et al.
Nature Medicine
|
October 24, 2018
A biobank of patient-derived pediatric brain tumor models
Sebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.
The Journal of Experimental Medicine
|
April 6, 2019
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
Stephen C Mack, Irtisha Singh, Xiuxing Wang, et al.
Cancer Discovery
|
October 7, 2021
Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
Zhixin Qiu, Linjie Zhao, Jia Z Shen, et al.
Nature Communications
|
July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
Matija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Nature Communications
|
September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
Kristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Cancer Discovery
|
August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
Giulia Montuori, Fengyu Tu, Di Qin, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Nature Medicine
|
September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors
Julia E Neumann, Annika K Wefers, Sander Lambo, et al.
Cancer Discovery
|
July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
Briana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Cancer Cell
|
January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation
Serap Erkek, Pascal D Johann, Martina A Finetti, et al.
Developmental Cell
|
June 4, 2024
Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression
Ryo Shiraishi, Gabriele Cancila, Kohei Kumegawa, et al.
Nature Medicine
|
October 24, 2018
A biobank of patient-derived pediatric brain tumor models
Sebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.
The Journal of Experimental Medicine
|
April 6, 2019
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
Stephen C Mack, Irtisha Singh, Xiuxing Wang, et al.
Cancer Discovery
|
October 7, 2021
Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
Zhixin Qiu, Linjie Zhao, Jia Z Shen, et al.
Nature Communications
|
July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
Matija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Nature Communications
|
September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
Kristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Cancer Discovery
|
August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
Giulia Montuori, Fengyu Tu, Di Qin, et al.
Page
of 8